Best Blue Chip Stocks To Own For 2019

tags:AXGN,JCS,IPI,ZUMZ,KONE,

U.S. stocks opened firmly higher on Thursday, extending a late-session rally from the prior session, as investors dialed back on fears that a trade spat between the U.S. and China will materialize.

The major equity indexes staged a big turnaround Wednesday after opening sharply lower, as traders struggled to interpret the possible impact of the trade standoff on U.S. corporate earnings and growth.

What are main benchmarks doing?

Dow Jones Industrial Average DJIA, +0.69% rise rose about 150 points, or 0.6%, to 24,410. Blue chips are attempting to mark their first three-session win streak since the three-day period ended Feb. 26, according to FactSet data. The S&P 500 index SPX, +0.46%  was up 12 points, or 0.4%, to 2,656, led by a 1.2% gain in energy and a 0.8% climb in technology stocks.

Best Blue Chip Stocks To Own For 2019: AxoGen, Inc.(AXGN)

Advisors' Opinion:

• [By Max Byerly]

  AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

• [By Ethan Ryder]

  Swiss National Bank lifted its stake in AxoGen, Inc Common Stock (NASDAQ:AXGN) by 5.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,200 shares of the medical equipment provider’s stock after purchasing an additional 2,800 shares during the period. Swiss National Bank owned about 0.14% of AxoGen, Inc Common Stock worth $2,623,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  These are some of the media stories that may have impacted Accern’s analysis:

  Get AxoGen alerts: Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

  AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

• [By Maxx Chatsko]

  Shares of AxoGen (NASDAQ:AXGN) fell nearly 19% today after the company reported second-quarter 2018 earnings. The healthcare company, which develops and markets surgical solutions for peripheral nerves, actually reported a solid quarter of sales growth compared to the year-ago period. Revenue increased 36% compared to the second quarter of 2017.

• [By Lee Jackson]

  Jefferies started coverage on this top biotech/medtech firm last year with a Buy rating. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

• [By Lee Jackson]

  Jefferies started coverage on this biotech/medical technology company with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

Best Blue Chip Stocks To Own For 2019: Communications Systems Inc.(JCS)

Advisors' Opinion:

• [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 42.76 percent to close at $16.56 on Wednesday in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million. Yangtze River Port and Logistics Limited (NASDAQ: YRIV) gained 31.28 percent to close at $7.05 on Wednesday. Tiffany & Co. (NYSE: TIF) climbed 23.29 percent to close at $126.05 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. EVO Payments, Inc. (NASDAQ: EVOP) gained 18.88 percent to close at $19.02. EVO Payments priced its IPO at $16 per share. Carver Bancorp, Inc. (NASDAQ: CARV) rose 16.1 percent to close at $6.85. USA Technologies, Inc. (NASDAQ: USAT) gained 15.68 percent to close at $13.65 after announcing pricing of public offering. eXp World Holdings, Inc. (NASDAQ: EXPI) shares jumped 15.01 percent to close at $17.70. Geron Corporation (NASDAQ: GERN) gained 14.99 percent to close at $4.68. Evolus, Inc. (NASDAQ: EOLS) rose 14.62 percent to close at $19.36. Ralph Lauren Corporation (NYSE: RL) shares rose 14.34 percent to close at $133.33 after the company reported stronger-than-expected results for its fourth quarter. Turtle Beach Corporation (NASDAQ: HEAR) jumped 13.26 percent to close at $17.34 on Wednesday. Turtle Beach S-3 showed registration for 1.857 million share common stock offering via selling holders. Communications Systems, Inc. (NASDAQ: JCS) rose 13.18 percent to close at $3.95. Communications Systems reported establishment of special committee to explore strategic alternatives. Immutep Limited (NASDAQ: IMMP) shares climbed 12.95 percent to close at $2.53. xG Technology, Inc. (NASDAQ: XGTI) rose 12.64 percent to close at $0.8561 after the company&rsq

Best Blue Chip Stocks To Own For 2019: Intrepid Potash, Inc(IPI)

Advisors' Opinion:

• [By Lisa Levin]

  Wednesday morning, the materials shares rose 0.83 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), up 8 percent, and Braskem S.A. (NYSE: BAK) up 6 percent.

• [By Maxx Chatsko]

  While the global fertilizer industry continues to struggle with imbalanced markets, efforts hyper-focused on operational efficiency have begun to pay off for several producers. Investors can count small cap Intrepid Potash (NYSE:IPI) among them.

• [By Logan Wallace]

  Intrepid Potash, Inc. (NYSE:IPI) insider Robert P. Jornayvaz III purchased 6,900 shares of the firm’s stock in a transaction that occurred on Monday, August 13th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $23,184.00. Following the completion of the purchase, the insider now directly owns 1,206,650 shares in the company, valued at approximately $4,054,344. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

• [By Ethan Ryder]

  Intrepid Potash (NYSE:IPI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “INTREPID POTASH, Inc. is the largest producer of potash in the U.S. and is dedicated to the production and marketing of potash and langbeinite, another mineral containing potassium. Intrepid owns five active potash production facilities — three in New Mexico and two in Utah “

Best Blue Chip Stocks To Own For 2019: Zumiez Inc.(ZUMZ)

Advisors' Opinion:

• [By Max Byerly]

  Divisar Capital Management LLC reduced its position in shares of Zumiez Inc. (NASDAQ:ZUMZ) by 81.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 26,994 shares of the apparel and footwear maker’s stock after selling 120,085 shares during the period. Zumiez comprises approximately 0.2% of Divisar Capital Management LLC’s holdings, making the stock its 26th largest position. Divisar Capital Management LLC’s holdings in Zumiez were worth $676,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Shane Hupp]

  Zumiez (NASDAQ:ZUMZ) CEO Richard Miles Brooks sold 3,957 shares of Zumiez stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $27.00, for a total transaction of $106,839.00. Following the completion of the sale, the chief executive officer now owns 3,709,067 shares in the company, valued at approximately $100,144,809. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

• [By Ethan Ryder]

  DA Davidson initiated coverage on shares of Zumiez (NASDAQ:ZUMZ) in a report published on Tuesday, The Fly reports. The firm issued a neutral rating on the apparel and footwear maker’s stock.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Zumiez (ZUMZ)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Motley Fool Staff]

  Zumiez (NASDAQ:ZUMZ) Q1 2018 Earnings Conference CallJun. 7, 2018 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Best Blue Chip Stocks To Own For 2019: Kingtone Wirelessinfo Solution Holding Ltd(KONE)

Advisors' Opinion:

• [By Money Morning News Team]

  While a 209% gain is exciting, FunctionX's gains are in the past. After looking at the 10 top penny stocks to watch this week, we'll show you a small-cap stock with serious profit potential ahead of it…

  Penny Stock Current Share Price Law Week's Gain FunctionX Inc. (OTCMKTS: FNCX) $0.03 209% Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73% DPW Holdings Inc. (NYSE: DPW) $1.16 51.31% Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33% MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21% Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42% Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30% International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64% Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14% Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

  As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it's important to note that investing in penny stocks is also inherently risky.